Indications for cholesterol-lowering medication: comparison of risk-assessment methods.
Background: Recommendations for the prescription of lipid-lowering drugs emphasise the importance of an assessment of absolute coronary heart disease (CHD) risk based on all risk factors, rather than simply the serum cholesterol concentration. If, however, the methods recommended for risk assessment...
| Publicado en: | Lancet Vol. 353; no. 9149; pp. 278 - 282 |
|---|---|
| Autores principales: | , , , , , , , , , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Lancet
1/23/1999
|
| Acceso en línea: | Ver este registro en EBSCOhost |